Incidence and Mortality of Cervical Cancer in the Republic of Kazakhstan: 2007-2016
-
Gulnar SHALGUMBAYEVA
,
Almagul ZHABAGINA
,
Anargul KUANYSHEVA
,
Marat SANDYBAYEV
,
Raida FAIZOVA
,
Tatyana BELIKHINA
,
Alexander PROKAZYUK
,
Nataliya KULABUKHOVA
,
Yuliya SEMENOVA
Abstract
Background: Epidemiology of cervical cancer is relatively well studied in developed countries of the world, but little is known about Central Asian states. This study aimed to analyze the changing patterns of cervical cancer incidence and mortality in the Republic of Kazakhstan.
Methods: The statistical analysis of official data on cervical cancer mortality and morbidity was performed for the whole country. Data on cervical cancer patients were retrieved for the period 2007-2016.
Results: There was an increase in the incidence of cervical cancer among the population of Kazakhstan from 15.24 per 100,000 in 2007 to 18.83 per 100,000 in 2016. This might be attributed to the introduction of national health program in 2011, which improved early identification. Over the last few years, the decreasing cervical cancer mortality is observed influenced by early diagnosis. The age-standardized incidence rates show that the majority of cervical cancer cases occur in the 40-49 yr age group.
Conclusion: The incidence of and mortality from cervical cancer in Kazakhstan in 2007-2016 are comparable with those in the neighboring former Soviet Union countries. Significant variations in incidence and mortality rates and one-year cancer-specific survival were observed between country regions.
1. Ferlay J, Shin HR, Bray F et al (2010). Estimates of worldwide burden of cancer in 2008: GLO-BOCAN 2008. Int J Cancer, 127(12): 2893–2917.
2. Arbyn M, Castellsagué X, de Sanjosé S et al (2011). Worldwide burden of cervical cancer in 2008. Ann Oncol, 22(12): 2675–2686.
3. Dauletyarova M, Semenova Y, Kaylubaeva G et al (2016). Are Women of East Kazakhstan Satisfied with the Quality of Maternity Care? Implementing the WHO Tool to Assess the Quality of Hospital Services. Iran J Public Health, 45(6): 729-38.
4. Dauletyarova MA, Semenova YM, Kaylubaeva G et al (2018). Are Kazakhstani Women Satisfied with Antenatal Care? Implementing the WHO Tool to Assess the Quality of Antenatal Services. Int J Envi-ron Res Public Health, 15(2):E325.
5. World cancer report. WHO Geneva 2014. 632 p. http://publications.iarc.fr/Non-Series-Publications/World-Cancer-Reports (accessed 23 July 2018)
6. Jemal A, Bray F, Ferlay J (2011). Global Cancer Statis-tics. Ca Cancer J Clin, 68(6):394-424.
7. Clemmens DA, Knafl K, Lev EL, McCorkle R (2018). Cervical cancer: patterns of long-term sur-vival. Oncol Nurs Forum, 35(6): 897–903.
8. Kaprin AD, Starinski VV, Petrova GV. (2015). Ma-lignancies in Russia in 2013: incidence and mortali-ty. Moscow, Russia, 250 p. ISBN 978-5-85502-205-6.
9. Grjibovski AM, Dubovichenko D, Saduakassova S et al (2018). Incidence, mortality and determinants of survival from cervical cancer in Northwest Russia: a registry-based cohort study. Int Health , 10(2): 92-99.
10. Ospanov Е, Adylkhanov Т, Tokanova S et al (2017). [Mortality and morbidity from prostate cancer in the Republic of Kazakhstan from 2007 to 2016]. Georgian Med News, (272): 17-22.
11. Chissov V.I., Starinski VV, Petrova GV. (2010). The state of cancer care in Russia in 2010. Moscow, Russia, 196 p. ISBN 978-5-85502-140-0
12. Breslow NE, Day NE (1987). Statistical methods in cancer research. Volume II--The design and anal-ysis of cohort studies. IARC Sci Publ, (82):1-406.
13. Igissinov N, Nuralina I, Igissinova G et al (2012). Ep-idemiological aspects of morbidity and mortality from cervical cancer in Kazakhstan. Asian Pac J Cancer Prev, 13(5): 2345-8.
14. World Health Organization. GLOBOCAN 2012: estimated cancer incidence, mortality and preva-lence worldwide in 2012. Geneva: WHO. http://globocan.iarc.fr/Default.aspx (accessed 7 July 2018).
15. Bray F, Lortet-Tieulent J, Znaor A et al (2013). Pat-terns and Trends in Human Papillomavirus-Related Diseases in Central and Eastern Europe and Central Asia. Vaccine,7: H32–45.
16. Yelissinova N, Grjibovski AM.,Yelissinova A et al (2015). Sociodemographic factors associated with infant abandonment in maternity hospitals in Ka-zakhstan: A case-control study. Public Health, 129(7): 1010-1013.
17. Benard VB, Thomas CC, King J et al (2014). Vital signs: cervical cancer incidence, mortality, and screening–United States, 2007-2012. MMWR Morb Mortal Wkly Rep, 63(44): 1004-9.
18. Obel J, Souares Y, Hoy D et al (2014). A systematic review of cervical cancer incidence and mortality in the Pacific Region. Asian Pac J Cancer Prev, 15(21): 9433-7.
19. Rogovskaya SI, Shabalova IP, Mikheeva IV et al (2013). Human Papillomavirus Prevalence and Type-Distribution, Cervical Cancer Screening Practices and Current Status of Vaccination Im-plementation in Russian Federation, the Western Countries of the Former Soviet Union, Caucasus Region and Central Asia. Vaccine, 7: H46–58.
20. Bekmukhambetov Y, Balmagambetova S, Jarkenov T et al (2016). Distribution of High Risk Human Papillomavirus Types in Western Kazakhstan – Retrospective Analysis of PCR Data. Asian Pac J Cancer Prev, 17(5): 2667-72.
21. Kaidarova DR. Experience of cervical cancer screen-ing in the Republic of Kazakhstan. Eurasian Can-cer Screening Conference. Minsk, Belarus, 17-18 May 2018. https://onco.kz/wp-content/uploads/2018/05/Cervical_Minsk.RUS_.pdf
22. Walters S, Quaresma M, Coleman MP et al (2011). Geographical variation in cancer survival in Eng-land, 1991-2006: an analysis by Cancer Network.J Epidemiol Community Health, 65(11): 1044-52.
23. Quinn MJ, Cooper N, Rachet B et al (2008). Survival from cancer of the uterine cervix in England and Wales up to 2001. Br J Cancer, 99 (Suppl 1): S59–S62.
24. Mathew A, George PS (2009). Trends in incidence and mortality rates of squamous cell carcinoma and adenocarcinoma of cervix – worldwide. Asian Pac J Cancer Prev, 10(4): 645–50.
25. Kausova G, Eleubaeva J, Shibanova A, Kusainova B (2013). [The problem of early detection of cervical cancer in the Republic of Kazakhstan]. Georgian Med News, (217): 11-15.
26. Hudson EA, Coleman DV, Brown CL (1990). The 1988 Bethesda System for reporting cervi-cal/vaginal cytologic diagnoses. Acta Cytol, 34(6): 902-3.
27. Mustafina MD (2014). Medical organizational and preventive measures to improve the health of women with common forms of reproductive system cancer in Kazakhstan. Oncology, 3: 56-58.
2. Arbyn M, Castellsagué X, de Sanjosé S et al (2011). Worldwide burden of cervical cancer in 2008. Ann Oncol, 22(12): 2675–2686.
3. Dauletyarova M, Semenova Y, Kaylubaeva G et al (2016). Are Women of East Kazakhstan Satisfied with the Quality of Maternity Care? Implementing the WHO Tool to Assess the Quality of Hospital Services. Iran J Public Health, 45(6): 729-38.
4. Dauletyarova MA, Semenova YM, Kaylubaeva G et al (2018). Are Kazakhstani Women Satisfied with Antenatal Care? Implementing the WHO Tool to Assess the Quality of Antenatal Services. Int J Envi-ron Res Public Health, 15(2):E325.
5. World cancer report. WHO Geneva 2014. 632 p. http://publications.iarc.fr/Non-Series-Publications/World-Cancer-Reports (accessed 23 July 2018)
6. Jemal A, Bray F, Ferlay J (2011). Global Cancer Statis-tics. Ca Cancer J Clin, 68(6):394-424.
7. Clemmens DA, Knafl K, Lev EL, McCorkle R (2018). Cervical cancer: patterns of long-term sur-vival. Oncol Nurs Forum, 35(6): 897–903.
8. Kaprin AD, Starinski VV, Petrova GV. (2015). Ma-lignancies in Russia in 2013: incidence and mortali-ty. Moscow, Russia, 250 p. ISBN 978-5-85502-205-6.
9. Grjibovski AM, Dubovichenko D, Saduakassova S et al (2018). Incidence, mortality and determinants of survival from cervical cancer in Northwest Russia: a registry-based cohort study. Int Health , 10(2): 92-99.
10. Ospanov Е, Adylkhanov Т, Tokanova S et al (2017). [Mortality and morbidity from prostate cancer in the Republic of Kazakhstan from 2007 to 2016]. Georgian Med News, (272): 17-22.
11. Chissov V.I., Starinski VV, Petrova GV. (2010). The state of cancer care in Russia in 2010. Moscow, Russia, 196 p. ISBN 978-5-85502-140-0
12. Breslow NE, Day NE (1987). Statistical methods in cancer research. Volume II--The design and anal-ysis of cohort studies. IARC Sci Publ, (82):1-406.
13. Igissinov N, Nuralina I, Igissinova G et al (2012). Ep-idemiological aspects of morbidity and mortality from cervical cancer in Kazakhstan. Asian Pac J Cancer Prev, 13(5): 2345-8.
14. World Health Organization. GLOBOCAN 2012: estimated cancer incidence, mortality and preva-lence worldwide in 2012. Geneva: WHO. http://globocan.iarc.fr/Default.aspx (accessed 7 July 2018).
15. Bray F, Lortet-Tieulent J, Znaor A et al (2013). Pat-terns and Trends in Human Papillomavirus-Related Diseases in Central and Eastern Europe and Central Asia. Vaccine,7: H32–45.
16. Yelissinova N, Grjibovski AM.,Yelissinova A et al (2015). Sociodemographic factors associated with infant abandonment in maternity hospitals in Ka-zakhstan: A case-control study. Public Health, 129(7): 1010-1013.
17. Benard VB, Thomas CC, King J et al (2014). Vital signs: cervical cancer incidence, mortality, and screening–United States, 2007-2012. MMWR Morb Mortal Wkly Rep, 63(44): 1004-9.
18. Obel J, Souares Y, Hoy D et al (2014). A systematic review of cervical cancer incidence and mortality in the Pacific Region. Asian Pac J Cancer Prev, 15(21): 9433-7.
19. Rogovskaya SI, Shabalova IP, Mikheeva IV et al (2013). Human Papillomavirus Prevalence and Type-Distribution, Cervical Cancer Screening Practices and Current Status of Vaccination Im-plementation in Russian Federation, the Western Countries of the Former Soviet Union, Caucasus Region and Central Asia. Vaccine, 7: H46–58.
20. Bekmukhambetov Y, Balmagambetova S, Jarkenov T et al (2016). Distribution of High Risk Human Papillomavirus Types in Western Kazakhstan – Retrospective Analysis of PCR Data. Asian Pac J Cancer Prev, 17(5): 2667-72.
21. Kaidarova DR. Experience of cervical cancer screen-ing in the Republic of Kazakhstan. Eurasian Can-cer Screening Conference. Minsk, Belarus, 17-18 May 2018. https://onco.kz/wp-content/uploads/2018/05/Cervical_Minsk.RUS_.pdf
22. Walters S, Quaresma M, Coleman MP et al (2011). Geographical variation in cancer survival in Eng-land, 1991-2006: an analysis by Cancer Network.J Epidemiol Community Health, 65(11): 1044-52.
23. Quinn MJ, Cooper N, Rachet B et al (2008). Survival from cancer of the uterine cervix in England and Wales up to 2001. Br J Cancer, 99 (Suppl 1): S59–S62.
24. Mathew A, George PS (2009). Trends in incidence and mortality rates of squamous cell carcinoma and adenocarcinoma of cervix – worldwide. Asian Pac J Cancer Prev, 10(4): 645–50.
25. Kausova G, Eleubaeva J, Shibanova A, Kusainova B (2013). [The problem of early detection of cervical cancer in the Republic of Kazakhstan]. Georgian Med News, (217): 11-15.
26. Hudson EA, Coleman DV, Brown CL (1990). The 1988 Bethesda System for reporting cervi-cal/vaginal cytologic diagnoses. Acta Cytol, 34(6): 902-3.
27. Mustafina MD (2014). Medical organizational and preventive measures to improve the health of women with common forms of reproductive system cancer in Kazakhstan. Oncology, 3: 56-58.
| Files | ||
| Issue | Vol 49 No 6 (2020) | |
| Section | Original Article(s) | |
| DOI | https://doi.org/10.18502/ijph.v49i6.3364 | |
| Keywords | ||
| Cervical cancer Incidence Mortality Kazakhstan Republic Survival | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
How to Cite
1.
SHALGUMBAYEVA G, ZHABAGINA A, KUANYSHEVA A, SANDYBAYEV M, FAIZOVA R, BELIKHINA T, PROKAZYUK A, KULABUKHOVA N, SEMENOVA Y. Incidence and Mortality of Cervical Cancer in the Republic of Kazakhstan: 2007-2016. Iran J Public Health. 2020;49(6):1120-1128.
